These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 12496180)
1. A GRA1 DNA vaccine primes cytolytic CD8(+) T cells to control acute Toxoplasma gondii infection. Scorza T; D'Souza S; Laloup M; Dewit J; De Braekeleer J; Verschueren H; Vercammen M; Huygen K; Jongert E Infect Immun; 2003 Jan; 71(1):309-16. PubMed ID: 12496180 [TBL] [Abstract][Full Text] [Related]
2. Toxoplasma gondii: Protective immunity induced by a DNA vaccine expressing GRA1 and MIC3 against toxoplasmosis in BALB/c mice. Gong P; Cao L; Guo Y; Dong H; Yuan S; Yao X; Ren W; Yao L; Xu Z; Sun Q; Zhang X Exp Parasitol; 2016 Jul; 166():131-6. PubMed ID: 27059254 [TBL] [Abstract][Full Text] [Related]
3. DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice. Vercammen M; Scorza T; Huygen K; De Braekeleer J; Diet R; Jacobs D; Saman E; Verschueren H Infect Immun; 2000 Jan; 68(1):38-45. PubMed ID: 10603366 [TBL] [Abstract][Full Text] [Related]
4. GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii. Jongert E; de Craeye S; Dewit J; Huygen K Parasite Immunol; 2007 Sep; 29(9):445-53. PubMed ID: 17727568 [TBL] [Abstract][Full Text] [Related]
5. Toxoplasma gondii: protective immunity induced by rhoptry protein 9 (TgROP9) against acute toxoplasmosis. Chen J; Zhou DH; Li ZY; Petersen E; Huang SY; Song HQ; Zhu XQ Exp Parasitol; 2014 Apr; 139():42-8. PubMed ID: 24602875 [TBL] [Abstract][Full Text] [Related]
6. Functional characterization of in vivo effector CD4(+) and CD8(+) T cell responses in acute Toxoplasmosis: an interplay of IFN-gamma and cytolytic T cells. Jongert E; Lemiere A; Van Ginderachter J; De Craeye S; Huygen K; D'Souza S Vaccine; 2010 Mar; 28(13):2556-64. PubMed ID: 20117266 [TBL] [Abstract][Full Text] [Related]
7. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice. Chen J; Huang SY; Zhou DH; Li ZY; Petersen E; Song HQ; Zhu XQ Vaccine; 2013 Dec; 31(52):6225-31. PubMed ID: 24183979 [TBL] [Abstract][Full Text] [Related]
8. Protective immunity induced by vaccination with SAG1 gene-transfected cells against Toxoplasma gondii-infection in mice. Aosai F; Mun HS; Norose K; Chen M; Hata H; Kobayashi M; Kiuchi M; Stauss HJ; Yano A Microbiol Immunol; 1999; 43(1):87-91. PubMed ID: 10100753 [TBL] [Abstract][Full Text] [Related]
9. Multicomponent DNA vaccine-encoding Toxoplasma gondii GRA1 and SAG1 primes: anti-Toxoplasma immune response in mice. Wu XN; Lin J; Lin X; Chen J; Chen ZL; Lin JY Parasitol Res; 2012 Nov; 111(5):2001-9. PubMed ID: 22837100 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of protective immunity induced by DNA vaccination with genes encoding Toxoplasma gondii GRA17 and GRA23 against acute toxoplasmosis in mice. Zhu WN; Wang JL; Chen K; Yue DM; Zhang XX; Huang SY; Zhu XQ Exp Parasitol; 2017 Aug; 179():20-27. PubMed ID: 28625894 [TBL] [Abstract][Full Text] [Related]
11. CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells. Hakim FT; Gazzinelli RT; Denkers E; Hieny S; Shearer GM; Sher A J Immunol; 1991 Oct; 147(7):2310-6. PubMed ID: 1918963 [TBL] [Abstract][Full Text] [Related]
12. DNA vaccine encoding the Toxoplasma gondii bradyzoite-specific surface antigens SAG2CDX protect BALB/c mice against type II parasite infection. Zhang M; Zhao L; Song J; Li Y; Zhao Q; He S; Cong H Vaccine; 2013 Sep; 31(41):4536-40. PubMed ID: 23933373 [TBL] [Abstract][Full Text] [Related]
13. An enhanced GRA1-GRA7 cocktail DNA vaccine primes anti-Toxoplasma immune responses in pigs. Jongert E; Melkebeek V; De Craeye S; Dewit J; Verhelst D; Cox E Vaccine; 2008 Feb; 26(8):1025-31. PubMed ID: 18221825 [TBL] [Abstract][Full Text] [Related]
14. Protective immunity induced by a DNA vaccine expressing eIF4A of Toxoplasma gondii against acute toxoplasmosis in mice. Chen J; Huang SY; Li ZY; Yuan ZG; Zhou DH; Petersen E; Zhang NZ; Zhu XQ Vaccine; 2013 Mar; 31(13):1734-9. PubMed ID: 23370151 [TBL] [Abstract][Full Text] [Related]
15. IL-15 prolongs the duration of CD8+ T cell-mediated immunity in mice infected with a vaccine strain of Toxoplasma gondii. Khan IA; Casciotti L J Immunol; 1999 Oct; 163(8):4503-9. PubMed ID: 10510393 [TBL] [Abstract][Full Text] [Related]
16. Induction of protective immune responses by a multiantigenic DNA vaccine encoding GRA7 and ROP1 of Toxoplasma gondii. Quan JH; Chu JQ; Ismail HA; Zhou W; Jo EK; Cha GH; Lee YH Clin Vaccine Immunol; 2012 May; 19(5):666-74. PubMed ID: 22419676 [TBL] [Abstract][Full Text] [Related]
17. Toxoplasma gondii: Vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice. Cao A; Liu Y; Wang J; Li X; Wang S; Zhao Q; Cong H; He S; Zhou H Vaccine; 2015 Nov; 33(48):6757-62. PubMed ID: 26518401 [TBL] [Abstract][Full Text] [Related]
18. Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene. Nielsen HV; Lauemøller SL; Christiansen L; Buus S; Fomsgaard A; Petersen E Infect Immun; 1999 Dec; 67(12):6358-63. PubMed ID: 10569750 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis. Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690 [TBL] [Abstract][Full Text] [Related]
20. Protective efficacy induced by DNA prime and recombinant protein boost vaccination with Toxoplasma gondii GRA14 in mice. Pagheh AS; Sarvi S; Gholami S; Asgarian-Omran H; Valadan R; Hassannia H; Ahmadpour E; Fasihi-Ramandie M; Dodangeh S; Hosseni-Khah Z; Daryani A Microb Pathog; 2019 Sep; 134():103601. PubMed ID: 31212035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]